Monthly information on share capital and company voting rights
(Article 223-16 of General Regulation of the French financial markets authority) Listing market: Euronext GrowthISIN code: FR0010425595 DateTotal number of shares in the capitalTotal number of voting rights 10/31/2024100,093,87388,569,210For further information on Cellectis, please contact: Media contact: Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33,[email protected] Patricia Sosa Navarro, Chief of Staff to the...
Comunicato Precedente
Comunicato Successivo
PARIS,
(informazione.it - comunicati stampa - salute e benessere)
Listing market: Euronext Growth
ISIN code: FR0010425595
Date | Total number of shares in the capital |
Total number of voting rights |
10/31/2024 | 100,093,873 | 88,569,210 |
For further information on Cellectis, please contact:
Media contact:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, [email protected]
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93
Investor Relations contacts:
Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, [email protected]
Attachment
Per maggiori informazioni
Sito Web
cellectis.com
Ufficio Stampa
Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti